Li-Fraumeni syndrome |
LFS; Sarcoma family syndrome of Li and Fraumeni; Sarcoma, breast, leukemia, and adrenal gland (SBLA) syndrome; SBLA syndrome |
Clinical Trial: Brain Imaging and Pain in Irritable Bowel Syndrome
This study is no longer recruiting patients.
|
Purpose
| Condition | Treatment or Intervention |
|---|---|
| Irritable Bowel Syndrome | Drug: placebo |
MedlinePlus related topics: Irritable Bowel Syndrome
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Double-Blind, Factorial Assignment
Official Title: Brain Imaging and Pain: Analysis of Placebo Analgesia
Expected Total Enrollment: 50
Study start: September 2003; Study completion: September 2006
Eligibility
Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
- Irritable Bowel Syndrome
- English speaking
Exclusion criteria:
- Chronic pain condition other than Irritable Bowel Syndrome
- Medical condition that would contraindicate use of lidocaine
- Clinical criteria for fibromyalgia
- Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
- Seropositive HIV
- Pregnancy
Location Information
Florida
University of Florida, Gainesville, Florida, 32610, United States
Michael E Robinson, PhD, Principal Investigator, University of Florida
More Information
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: July 31, 2003
ClinicalTrials.gov Identifier: NCT00065754
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Not Signed In -


